FindTrial
Sign In

Platelet rich plasma therapy in patients of leprosy

EFFECT OF PLATELET RICH PLASMA THERAPY ON RADIOLOGICAL AND ELECTROPHYSIOLOGICAL PARAMETERS OF ULNAR NERVE IN PATIENTS OF LEPROSY: A HOSPITAL BASED PROSPECTIVE COMPARATIVE STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054394
Enrollment
24
Registered
2023-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A304- Borderline lepromatous leprosy

Interventions

Intervention1: Perineural Platelet Rich Plasma (PRP)therapy: Dose -1cc Frequency -monthly intervel Route of administration-after palpating the sulcus nervi ulnaris between medial epicondylus and olecr

Sponsors

Shri Ram Murti Smark Institute of Medical and Health Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients attending leprosy clinic Patients with bilateral palpable thickened nerves

Exclusion criteria

Exclusion criteria: Patients refusing to participate in the study Patients not willing to give written informed consent Patients below 18 yrs and above 50 yrs

Design outcomes

Primary

MeasureTime frame
Platelet rich plasma shows improvement in nerve conduction and ultrasonographic parameters in neuritis in patients of leprosyTimepoint: Baseline and 4 months—

Secondary

MeasureTime frame
is the improvement in nerve conduction parameters corresponding to ultrasonographic parametersTimepoint: 4 months—

Countries

India

Contacts

Public ContactShikhil Gupta

Shri Ram Murti Smark Institute of Medical and Health Sciences,Bhojipura,bareilly

drpratikg@rediffmail.com9319758004

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026